We are international
Donate
• health professionals TEXT SIZE   


KOS 2007: The Treatment of Relapsed and Refractory Myeloma: Focus on Bortezomib and Bortezomib-based Combinations
Paul Richardson, MD
Medical Oncology
Dana Farber Cancer Institute
Harvard Medical School
Boston, MA, USA
06.27.07
kos/Kos-2007-3-1-Richardson.flv

Audio of Dr. Richardson's presentation.


 related articles